Discovery Laboratories (DSCO)
Add to Watchlists Create an AlertDSCO Key Stats
| Income Statement | |
| Revenue TTM | 0.267M |
| Revenue Quarterly YoY Growth | |
| EPS Diluted TTM | -0.917 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -39.93M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | -17549% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 70.46M |
| Enterprise Value | 50.17M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 7.451 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.6432 |
| Free Cash Flow | -10.36M |
| Return on Equity | -155.9% |
DSCO News
- SmithOnStocks Opines On Stocks: May 19th Edition May 19
- 7 Biotechnology Stocks to Sell Now Investor Place May 15
- Discovery Labs Announces Completion of $14.25 Million Public Offering PR Newswire May 15
- Discovery Labs to Float Stock Issue May 10
- Discovery Labs (DSCO) Prices 9.5M Common Stock Offering Street Insider May 10
- Discovery Labs Prices $14.25 Million Public Offering of Common Stock PR Newswire May 10
- DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Entry into a Material Defini... May 10
- Discovery Labs files to sell common stock, no amount given May 9
- Discovery Labs (DSCO) Announces Common Stock Offering Street Insider May 9
- Discovery Labs Announces Proposed Public Offering of Common Stock PR Newswire May 9
DSCO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Discovery Laboratories is down 36.72% over the last year vs S&P 500 Total Return up 28.68%, Acorda Therapeutics up 45.58%, and Achillion Pharmaceuticals up 7.49%.
DSCO Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these DSCO related companies
Pro Ratings for DSCO
Pro Report PDF for DSCO
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download DSCO Pro Report PDF
Pro Strategies Featuring DSCO
Did Discovery Laboratories make it into our Pro Portfolio Strategies?
DSCO Profile
Sector: Healthcare
Industry: Biotechnology
Other DSCO Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DSCO | 1.62 | -0.03 | -1.82% | 70.46M |
